Sanofi
SNY
573 hedge funds and large institutions have $8.71B invested in Sanofi in 2020 Q3 according to their latest regulatory filings, with 50 funds opening new positions, 200 increasing their positions, 202 reducing their positions, and 54 closing their positions.
122% more call options, than puts
Call options by funds: $37.7M | Put options by funds: $17M
0% more funds holding in top 10
Funds holding in top 10: 6 → 6 (0)
0.49% less ownership
Funds ownership: 14.28% → 13.79% (-0.49%)
1% less repeat investments, than reductions
Existing positions increased: 200 | Existing positions reduced: 202
5% less capital invested
Capital invested by funds: $9.15B → $8.71B (-$441M)
7% less first-time investments, than exits
New positions opened: 50 | Existing positions closed: 54
2% less funds holding
Funds holding: 582 → 573 (-9)
Top Buyers
| 1 |
RG
Redmile Group
San Francisco,
California
|
+$26.6M |
| 2 |
Fisher Asset Management
Camas,
Washington
|
+$24.1M |
| 3 |
Citigroup
New York
|
+$12.3M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$8.51M |
| 5 |
CCM
Causeway Capital Management
Los Angeles,
California
|
+$7.74M |
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$166M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
-$48M |
| 3 |
BlackRock
New York
|
-$25.4M |
| 4 |
CCMG
Clark Capital Management Group
Philadelphia,
Pennsylvania
|
-$24.6M |
| 5 |
Morgan Stanley
New York
|
-$23.8M |
SNY Hedge Fund Activity: Q3 2020 in Review
573 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Sanofi (SNY) for Q3 2020, worth a combined $8.71B — down 4.8% from $9.15B a quarter earlier.
Sellers outnumbered buyers: 54 funds closed out of SNY and 50 opened new positions — a net loss of 4 holders — while 202 trimmed existing stakes and 200 added.
The largest buyer was Redmile Group, adding an estimated $26.6M. The largest seller was Fidelity Investments, cutting an estimated $166M.
- 573 institutional investors held Sanofi (SNY) as of Q3 2020, down from 582 in Q2 2020.
- Funds reported $8.71B of Sanofi stock for Q3 2020, down 4.8% quarter-over-quarter.
- 50 funds opened new Sanofi positions in Q3 2020 and 54 closed out, a net change of -4 holders.
- The largest Sanofi buyer in Q3 2020 was Redmile Group, an estimated $26.6M added.
- The largest Sanofi seller in Q3 2020 was Fidelity Investments, an estimated $166M sold.
Based on aggregated 13F filings for Q3 2020.